Digital messages to help people quit flavored tobacco
Official title: Behavioral Intervention to Mitigate Nicotine Addiction in Digital Environments
Funded at Georgia State University · NIH-11304526 · Data updated 2026-11-12
This project uses tailored digital messages to help people who smoke flavored combusted tobacco try to quit.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | April 3, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $565,423 |
| NIH project number | 5R01CA289552-03 |
| Project ID | NIH-11304526 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults in the United States who currently smoke flavored combusted tobacco products and are willing to receive digital messages, especially those from socioeconomically disadvantaged groups.
✕Less likely to help
People who do not use flavored combusted tobacco, who do not engage with digital platforms, or who are not interested in quitting are unlikely to benefit.
What this research studies
You would help create and refine short digital messages aimed at people who smoke flavored cigarettes or other combusted tobacco. Researchers will run workshops and interviews with smokers to co-create message wording and images. They will use eye-tracking and discrete choice experiments to see which messages grab attention and are most persuasive. Finally, a nationwide randomized trial will test whether receiving these messages changes intentions to quit and actual quitting behavior.
Why it matters
Potential benefit: If successful, these messages could increase motivation and quitting rates for people who smoke flavored tobacco.
How similar studies have gone: Prior research shows tailored digital messaging can help some smokers quit, but combining co-creation, eye-tracking, and a national randomized trial for flavored-combustion users is relatively new.
Where this research is happening
-
Georgia State University
Atlanta, United States Active
Researchers
- Principal investigator: Popova, Lyudmila — Georgia State University
- Study coordinator: Popova, Lyudmila
Related research
Other NIH-funded projects on the same topics.
-
Reducing Addiction Risk in High Schools Through Better Prevention Infrastructure
Aims to build a sustainable, school-based system to prevent opioid and other drug use among high school students, especially those at higher risk.
-
HEAL Data Platform to share addiction-related data across programs
A platform project to make HEAL data from many programs easier to find and use, helping researchers and clinicians access information about addiction in children and youth.
-
Cognitively-enhanced tDCS to reduce cocaine craving
A study to test whether real brain stimulation together with learning strategies can lessen craving in people with cocaine use disorder.
-
Yale center researching how tobacco products affect use and addiction in people
A Yale research center is studying how nicotine, flavor additives, and other ingredients in tobacco products influence people’s likelihood of starting and becoming addicted.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
Integrating long-acting PrEP into street medicine for people who use drugs
This project tests whether a long-acting HIV prevention shot (lenacapavir) can be feasibly and acceptably offered by street-based health teams to people who use drugs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.